Table 2. Prevalence of pre-hypertension and the prevalence, awareness, treatment and control of hypertension among females and males who completed the surveys in 2001 and 2010.
| Total | Male | Female | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2001 (n = 2272) | 2010 (n = 2074) | P-value | 2001 (n = 943) | 2010 (n = 839) | P-value | 2001 (n = 1329) | 2010 (n = 1235) | P-value | P-value* | P-value# | |
| Crude prevalence | |||||||||||
| Current | |||||||||||
| Optimal | 289 (12.7) | 171 (8.2) | <0.001 | 118 (12.5) | 71 (8.5) | 0.006 | 171 (12.9) | 100 (8.1) | <0.001 | 0.803 | 0.767 |
| Pre-hypertension | 625 (27.5) | 494 (23.8) | 0.005 | 263 (27.9) | 228 (27.2) | 0.736 | 362 (27.2) | 266 (21.5) | 0.001 | 0.732 | 0.003 |
| Hypertension | 1358 (59.8) | 1409 (67.9) | <0.001 | 562 (59.6) | 540 (64.4) | 0.039 | 796 (59.9) | 869 (70.4) | <0.001 | 0.887 | 0.004 |
| Awareness | 953 (70.2) | 1058 (75.1) | 0.004 | 387 (68.9) | 388 (71.9) | 0.277 | 566 (71.1) | 670 (77.1) | 0.005 | 0.373 | 0.027 |
| Treatment | 693 (51.0) | 945 (67.1) | <0.001 | 284 (50.5) | 347 (64.3) | <0.001 | 409 (51.4) | 598 (68.8) | <0.001 | 0.758 | 0.077 |
| Control | 209 (15.4) | 417 (29.6) | <0.001 | 95 (16.9) | 168 (31.1) | <0.001 | 114 (14.3) | 249 (28.7) | <0.001 | 0.194 | 0.326 |
| Age- and sex-adjusted prevalence | |||||||||||
| Current | |||||||||||
| Optimal | 12.7 (11.3–14.1) | 9.3 (8.1–10.6) | <0.001 | 12.6 (10.5–14.7) | 9.9 (7.8–11.9) | 0.075 | 12.8 (11.0–14.6) | 9.0 (7.4–10.6) | 0.002 | 0.893 | 0.468 |
| Pre-hypertension | 27.2 (25.4–29.0) | 25.5 (23.6–27.4) | 0.207 | 28.0 (25.1–30.9) | 29.6 (26.5–32.7) | 0.448 | 26.7 (24.3–29.0) | 22.7 (20.4–25.1) | 0.021 | 0.495 | <0.001 |
| Hypertension | 60.1 (58.1–62.1) | 65.2 (63.1–67.2) | 0.001 | 59.4 (56.3–62.6) | 60.5 (57.2–63.9) | 0.628 | 60.6 (57.9–63.2) | 68.3 (65.7–70.9) | <0.001 | 0.597 | <0.001 |
| Awareness | 69.8 (67.4–72.3) | 74.5 (72.2–76.8) | 0.007 | 68.7 (64.8–72.6) | 72.0 (68.1–75.9) | 0.231 | 70.6 (67.5–73.8) | 76.0 (73.1–78.9) | 0.013 | 0.464 | 0.108 |
| Treatment | 50.6 (47.9–53.2) | 66.4 (63.9–68.9) | <0.001 | 50.3 (46.2–54.5) | 63.7 (59.5–67.9) | <0.001 | 50.7 (47.3–54.2) | 68.0 (64.9–71.2) | <0.001 | 0.863 | 0.100 |
| Control | 15.3 (13.4–17.2) | 30.0 (27.5–32.4) | <0.001 | 16.9 (13.8–20.0) | 31.1 (27.0–35.1) | <0.001 | 14.2 (11.8–16.6) | 29.3 (26.2–32.4) | <0.001 | 0.187 | 0.486 |
* 2001: male vs. female
# 2010: male vs. female